Active Ingredient(s): Pitolisant Hydrochloride
FDA Approved: * August 14, 2019
Category: Narcolepsy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Wakix Overview

Pitolisant, sold under the brand name Wakix, is a potent and highly selective histamine 3 (H) receptor antagonist/inverse agonist, representing the first commercially available medication in its class. Pitolisant enhances the activity of histaminergic neurons in the brain that function to improve a person's wakefulness and decrease the number of cataplexy attacks in people that suffer from narcolepsy.[1] History Pitolisant was developed by Jean-Charles Schwartz, Walter Schu...

Read more Wakix Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Pitolisant

Recent Wakix Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pitolisant Hydrochloride
  • Tablet: 17.8mg, 4.45mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Wakix: (2 results)

Sorted by National Drug Code
  • 72028-045 Wakix 4.45 mg Oral Tablet, Film Coated by Harmony Biosciences, LLC
  • 72028-178 Wakix 17.8 mg Oral Tablet, Film Coated by Harmony Biosciences, LLC

Other drugs which contain Pitolisant Hydrochloride or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 1 December 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA